Probiotec Limited  

(Public, ASX:PBP)   Watch this stock  
Find more results for Robert Tedder´┐Ż
0.000 (0.00%)
Oct 9 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.33 - 0.33
52 week 0.15 - 0.33
Open 0.33
Vol / Avg. 17,104.00/7,155.00
Mkt cap 17.47M
P/E     -
Div/yield     -
EPS -0.09
Shares 52.93M
Beta     -
Inst. own     -
Nov 27, 2015
Probiotec Ltd Annual Shareholders Meeting (Estimated) - 10:00AM GMT+11 - Add to calendar
Oct 6, 2015
Probiotec Ltd Annual Shareholders Meeting

Key stats and ratios

Q2 (Jun '15) 2015
Net profit margin 59.20% -7.26%
Operating margin 58.59% -8.19%
EBITD margin - 7.58%
Return on average assets 54.23% -5.37%
Return on average equity 104.01% -9.18%
Employees 111 -
CDP Score - -


83 Cherry Lane, Laverton North
Laverton North, VIC 3026
+61-3-92787555 (Phone)
+61-3-93696730 (Fax)

Website links


Probiotec Limited is engaged in the development, manufacture and sale of pharmaceuticals, foods and nutraceutical products in Australia and international markets. The Company operates in five segments: The branded pharmaceuticals segment involves the sale of branded pharmaceutical products (both owned and licensed brands) predominantly throughout Australia and also to slected South East Asian countries. The contract manufacturing segment involves the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies. The weight loss and sports nutrition segment is involved in the manufacture and sale of a range of products across a number of channels including FMCG, pharmacy, health food stores and online. The Europe segment is involved in the manufacture and sale of products within Europe. The specialty products segment is involved in the sale of human and animal nutrition products.

Officers and directors

Wesley Stringer CPA Chief Executive Officer, Executive Director
Jared Stringer CPA Chief Financial Officer, Company Secretary
Mark Thomas Chatfield General Manager - New Business
Dustin Stringer General Manager - Marketing
Humera Ahmad General Manager - Quality of Probiotec Pharma Pty Ltd.
Scott Patterson General Manager - Sales of Biotech Pharmaceuticals Pty Ltd.
Robert Maxwell Johnston Acting Non-Executive Independent Chairman of the Board
Robin John Tedder Non-Executive Director
Graham Harry Buckeridge Non-Executive Independent Director
Richard David Kuo Non-Executive Independent Director